Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary H Lyman

Showing results (1-10 of 442) with videos related to

Pageof 45
Sort By:
Journal of Oncology Practice|May 3, 2011
Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelinesGary H Lyman
Cancer Investigation|June 27, 2009
Comparative effectiveness research in oncology: the need for clarity, transparency and visionGary H Lyman
Clinical Advances in Hematology & Oncology : H&O|March 9, 2012
The incidence of venous thromboembolism in cancer patients: a real-world analysisGary H Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
New Biosimilar Approvals for Myeloid Growth Factors and AnemiaGary H Lyman
Current Opinion in Hematology|November 3, 2010
A comparison of international guidelines for the prevention of chemotherapy-induced neutropeniaGary H Lyman
Journal of Oncology Practice|September 22, 2010
Preventing venous thromboembolism in cancer patients: can we do better?Gary H Lyman
Oncology (Williston Park, N.Y.)|December 20, 2003
Risk assessment in oncology clinical practice. From risk factors to risk modelsGary H Lyman
Seminars in Oncology|September 26, 2003
Balancing the benefits and costs of colony-stimulating factors: a current perspectiveGary H Lyman
Clinical Cornerstone|March 24, 2007
Risks and consequences of chemotherapy-induced neutropeniaGary H Lyman
Oncology (Williston Park, N.Y.)|August 24, 2006
Benefits of early intervention with erythropoiesis- stimulating proteins in chemotherapy-induced anemiaGary H Lyman
Pageof 45

Showing results (1-10 of 442) with videos related to

Sort By:
Pageof 45
Journal of Oncology Practice|May 3, 2011
Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelinesGary H Lyman
Cancer Investigation|June 27, 2009
Comparative effectiveness research in oncology: the need for clarity, transparency and visionGary H Lyman
Clinical Advances in Hematology & Oncology : H&O|March 9, 2012
The incidence of venous thromboembolism in cancer patients: a real-world analysisGary H Lyman
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
New Biosimilar Approvals for Myeloid Growth Factors and AnemiaGary H Lyman
Current Opinion in Hematology|November 3, 2010
A comparison of international guidelines for the prevention of chemotherapy-induced neutropeniaGary H Lyman
Journal of Oncology Practice|September 22, 2010
Preventing venous thromboembolism in cancer patients: can we do better?Gary H Lyman
Oncology (Williston Park, N.Y.)|December 20, 2003
Risk assessment in oncology clinical practice. From risk factors to risk modelsGary H Lyman
Seminars in Oncology|September 26, 2003
Balancing the benefits and costs of colony-stimulating factors: a current perspectiveGary H Lyman
Clinical Cornerstone|March 24, 2007
Risks and consequences of chemotherapy-induced neutropeniaGary H Lyman
Oncology (Williston Park, N.Y.)|August 24, 2006
Benefits of early intervention with erythropoiesis- stimulating proteins in chemotherapy-induced anemiaGary H Lyman
Pageof 45